In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $6.42, marking a +1.58% move from the previous day. This move lagged the S&P 500's daily gain of 1.83%. On the other hand, the ...

Officials who oversee an international treaty governing endangered species recommended suspending shipments of long-tailed ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

The Greater Bay Area (GBA) has potential as a hub for biomedical innovation, thanks in part to Hong Kong’s basic research capabilities and status as a financial centre, but the region needs closer ...

The new Aurobindo facility will expand the single-stream manufacturing process of generic pharmaceuticals from manufacturing, ...

Residents who returned to unburned homes after a 2021 wildfire near Boulder, Colorado often reported health issues months ...

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

Trump’s war on science, however, has little to do with improving human or animal lives. He famously loves meat — especially ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Ideas: AI and democracy with Madeleine Daepp and Robert Osazuwa Ness ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS – Research Report), Quanterix ...

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...